How Should Ascites in Cirrhosis Be Evaluated and Treated?

Answer in brief: New or worsening ascites in cirrhosis requires diagnostic paracentesis to define the cause and exclude spontaneous bacterial peritonitis when clinically appropriate. Initial treatment usually combines dietary sodium restriction with diuretics—commonly spironolactone and furosemide—while monitoring renal function, sodium, potassium and weight. Tense or refractory ascites is treated with large-volume paracentesis plus albumin when >5 L is removed, and should prompt consideration of TIPS and liver-transplant evaluation.

Key clinical points

Do not assume every ascites episode is uncomplicated portal hypertension.
Diagnostic paracentesis is central in new-onset, hospitalized or clinically worsening ascites.
Use sodium restriction and carefully titrated diuretics for uncomplicated recurrent ascites.
Refractory ascites is a prognostic milestone and should trigger advanced-care planning.

Diagnostic paracentesis

Ascitic cell count/differential, albumin and total protein are core tests. The serum-ascites albumin gradient helps identify portal-hypertensive ascites. Culture should be obtained when infection is suspected, ideally by inoculating blood-culture bottles at the bedside. A neutrophil count ≥250 cells/mm³ supports spontaneous bacterial peritonitis and requires treatment.

Sodium and diuretics

A dietary sodium target near 2 g/day is commonly used. Spironolactone and furosemide are often started in a ratio that helps maintain potassium balance and are titrated according to weight, edema, blood pressure, creatinine and electrolytes. NSAIDs should be avoided because they can precipitate renal dysfunction and diuretic resistance.

Large-volume paracentesis

Tense symptomatic ascites is efficiently treated with paracentesis. When more than 5 L is removed, albumin replacement—commonly 6–8 g per liter removed—reduces post-paracentesis circulatory dysfunction.

Refractory ascites

Rapid recurrence, inability to mobilize fluid despite sodium restriction and tolerated diuretic therapy, or diuretic-limiting renal/electrolyte complications define a high-risk group. Serial paracentesis, TIPS in appropriate candidates and liver-transplant evaluation should be considered. Refractory ascites signals substantially worse prognosis even when MELD appears modest.

Practical approach

1. Perform diagnostic paracentesis in new or clinically worsening ascites.

2. Treat uncomplicated portal-hypertensive ascites with sodium restriction and titrated diuretics.

3. Use large-volume paracentesis plus albumin for tense ascites.

4. For refractory ascites, consider TIPS and transplant evaluation.

Common errors to avoid

Starting diuretics for new ascites without considering diagnostic paracentesis.
Continuing escalating diuretics despite renal dysfunction or severe electrolyte complications.

Trainee takeaway

New or worsening ascites in cirrhosis requires diagnostic paracentesis to define the cause and exclude spontaneous bacterial peritonitis when clinically appropriate. The examination question is usually less about memorizing one cutoff than recognizing which finding changes the next clinical decision.

Relevant free books by Dr. Alan B. R. Thomson

Thomson ABR. Guideline-Based Management in Hepatology. CAPstone Academic Publishers; 2015. ISBN 978-1502928078.
Thomson ABR. Mastering the Boards and Clinical Examinations in Internal Medicine: Hepatology. CAPstone Academic Publishers; 2016. ISBN 978-1519751195.

Free downloads: https://giandhepatology.com/free-medical-books-on-gastroenterology-and-hepatology

Frequently asked questions

Should every patient with ascites receive fluid restriction?

No. Fluid restriction is generally reserved for clinically significant hyponatremia rather than routine ascites management.

When should albumin be given after paracentesis?

AASLD guidance supports albumin with large-volume paracentesis, particularly when >5 L is removed, typically about 6–8 g per liter removed.

References

1. Thomson ABR. Guideline-Based Management in Hepatology. CAPstone Academic Publishers; 2015. ISBN 978-1502928078.

2. Thomson ABR. Mastering the Boards and Clinical Examinations in Internal Medicine: Hepatology. CAPstone Academic Publishers; 2016. ISBN 978-1519751195.

3. Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome. Hepatology. 2021;74:1014-1048.

Editorial note: This educational article synthesizes Dr. Thomson’s teaching framework with current society guidance. Recommendations should be checked against the latest guideline, local formulary, regulatory labeling and the individual clinical context before patient-specific use.